Sotera Health Company

NasdaqGS:SHC 株式レポート

時価総額:US$3.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Sotera Health マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Michael Petras

最高経営責任者

US$9.7m

報酬総額

CEO給与比率10.8%
CEO在任期間8yrs
CEOの所有権2.0%
経営陣の平均在職期間3.7yrs
取締役会の平均在任期間3.7yrs

経営陣の近況

Recent updates

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Nov 24
Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit

Sep 19

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sep 08
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sotera Health GAAP EPS of $0.11 misses by $0.05, revenue of $266.64M beats by $10.34M

Aug 04

Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

May 09
Is Sotera Health Company (NASDAQ:SHC) Trading At A 46% Discount?

Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Mar 16
Returns On Capital Are Showing Encouraging Signs At Sotera Health (NASDAQ:SHC)

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

Jan 19
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 38%?

CEO報酬分析

Sotera Health の収益と比較して、Michael Petras の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

US$55m

Dec 31 2023US$10mUS$1m

US$51m

Sep 30 2023n/an/a

-US$306m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$261m

Dec 31 2022US$17mUS$1m

-US$234m

Sep 30 2022n/an/a

US$121m

Jun 30 2022n/an/a

US$123m

Mar 31 2022n/an/a

US$135m

Dec 31 2021US$2mUS$1m

US$115m

Sep 30 2021n/an/a

US$36m

Jun 30 2021n/an/a

US$9m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$17mUS$728k

-US$39m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019US$2mUS$700k

-US$21m

報酬と市場: Michaelの 総報酬 ($USD 9.70M ) は、 US市場 ($USD 6.80M ) の同規模の企業の平均を上回っています。

報酬と収益: Michaelの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Michael Petras (55 yo)

8yrs

在職期間

US$9,701,005

報酬

Mr. Michael B. Petras Jr., serves as Chief Executive Officer at Sotera Health Company since June 20, 2016. He has been Chairman of the Board at Sotera Health Company since October 2020. He also served as t...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Michael Petras
Chairman & CEO8yrsUS$9.70m1.98%
$ 67.4m
Jonathan Lyons
Senior VP & CFOless than a yearUS$2.18mデータなし
Alexander Dimitrief
Senior VP1.6yrsUS$862.18k0.083%
$ 2.8m
Michael Rutz
President of Sterigenics3.7yrsUS$2.03m0.17%
$ 5.7m
Robert Hauzie
Chief Information Officer5.4yrsデータなしデータなし
Kristin Gibbs
Chief Marketing Officer7.6yrsデータなしデータなし
William Lehmann
Senior Vice President of Strategy & Corporate Development2.4yrsデータなしデータなし
Sally Turner
Chief Human Resources Officer5.4yrsデータなしデータなし
Kathleen Hoffman
Senior Vice President of Global Environmentalno dataデータなしデータなし
Joseph Shrawder
President of Nelson Labs3.7yrsデータなしデータなし
Riaz Bandali
President of Nordion2.3yrsデータなしデータなし
Jason Peterson
VP & Treasurerno dataデータなしデータなし

3.7yrs

平均在職期間

54.5yo

平均年齢

経験豊富な経営陣: SHCの経営陣は 経験豊富 であると考えられます ( 3.7年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Michael Petras
Chairman & CEO8yrsUS$9.70m1.98%
$ 67.4m
David Donnini
Independent Director3.7yrsUS$302.50k0.015%
$ 499.1k
James Neary
Independent Director3.7yrsUS$320.00k0.015%
$ 499.1k
Constantine Mihas
Independent Director3.7yrsUS$305.00k0.015%
$ 499.1k
Sean Cunningham
Independent Director3.7yrsUS$302.50k0.015%
$ 499.1k
Vincent Petrella
Independent Director3.6yrsUS$325.00k0.015%
$ 499.1k
Ann Klee
Independent Director3.7yrsUS$322.50k0.031%
$ 1.0m
Robert Knauss
Independent Director1.7yrsUS$300.00k0.0056%
$ 188.7k
Ruoxi Chen
Independent Director3.6yrsUS$302.50k0.015%
$ 499.1k
David Wheadon
Independent Director3.1yrsUS$310.00k0.013%
$ 428.7k
Karen Flynn
Independent Directorless than a yearUS$9.99kデータなし

3.7yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: SHCの 取締役会経験豊富 であると考えられます ( 3.7年の平均在任期間)。